Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM HACKENSACK, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Royal Biologics, a company specializing in Advanced Cellular Technologies & Enhanced Autologous Solutions, today announces the commercial...